FDA cleared the EFAI NEUROSUITE CTA LVO ASSESSMENT SYSTEM (LVO-CTA-100) from Ever Fortune.Ai, Co., Ltd. on Oct 30, 2026 under K263109, a traditional 510(k). The device falls under product code QAS, Radiological Computer-Assisted Triage And Notification Software, regulated at 21 CFR 892.2080 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Sep 4, 2026. The decision came 56 days later, inside the 90 FDA-day goal for a 510(k).

Ever Fortune.Ai, Co., Ltd. has 2 other decisions in the tracker over the last 12 months: K253163 (EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)), K251306 (Seg Pro V3 (RT-300)).